Provided by Tiger Trade Technology Pte. Ltd.

Werewolf Therapeutics, Inc.

0.9223
+0.01231.35%
Post-market: 0.8900-0.0323-3.50%19:54 EDT
Volume:828.56K
Turnover:757.33K
Market Cap:44.77M
PE:-1.23
High:0.9397
Open:0.9100
Low:0.8901
Close:0.9100
52wk High:2.15
52wk Low:0.2700
Shares:48.54M
Float Shares:45.38M
Volume Ratio:1.55
T/O Rate:1.83%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.7503
EPS(LYR):-1.3300
ROE:-119.86%
ROA:-27.39%
PB:2.75
PE(LYR):-0.69

Loading ...

OSI Systems (OSIS) Stock Drops 13% After Hours: Here’s What’s Going On?

Benzinga Earnings
·
Aug 21

Werewolf Therapeutics Monetizes Platforms, Refocuses on Lead Programs

TIPRANKS
·
Aug 21

Werewolf Therapeutics - Emd to Pay $28 Mln Upfront and $5 Mln on Completion of Asset Transfer - SEC Filing

THOMSON REUTERS
·
Aug 21

Werewolf Therapeutics - on August 14, Sells Inducer and Indukine Platforms to Emd Serono - SEC Filing

THOMSON REUTERS
·
Aug 21

Werewolf Therapeutics - Obtains Exclusive License from Emd for Wtx-124 and Wtx-330 Development - SEC Filing

THOMSON REUTERS
·
Aug 21

Werewolf Therapeutics Q2 EPS $0.08 Beats $(0.29) Estimate, Sales $21.000M

Benzinga Earnings
·
Jul 31

Werewolf Therapeutics Posts Q2 Profit on Jazz Asset Sale

Reuters
·
Jul 31

Werewolf Therapeutics Q2 FY26 Swings to Net Income of $3.7 Million; Revenue Rises to $21 Million

Reuters
·
Jul 31

Werewolf Therapeutics Q2 Basic EPS USD 0.08

THOMSON REUTERS
·
Jul 31

Werewolf Therapeutics Reports Second Quarter 2026 Financial Results and Recent Corporate Updates

THOMSON REUTERS
·
Jul 31

Werewolf Therapeutics Director Luke Evnin Reports Disposal of Common Shares Worth $44,155.83

Reuters
·
Jul 09

Werewolf Therapeutics Director Luke Evnin Disposes of 157,084 Common Shares for $47,125.2

Reuters
·
Jun 30

RA Capital Management disposes of Werewolf Therapeutics shares worth $145,069

Reuters
·
Jun 23

RA Capital Management disposes of $179,430 in Werewolf Therapeutics common shares

Reuters
·
Jun 17

RA Capital Management disposes of USD 254,920 of Werewolf Therapeutics common shares

Reuters
·
Jun 12

Werewolf Therapeutics director Luke Evnin disposes of 76,928 common shares worth $28,463.36

Reuters
·
Jun 11

Werewolf Therapeutics director Luke Evnin disposes of USD 42,706 in common shares

Reuters
·
Jun 09

Werewolf Therapeutics director Luke Evnin reports $64,796 common share disposal

Reuters
·
Jun 04

Werewolf Therapeutics director Luke Evnin disposes of USD 67,606 in common shares

Reuters
·
May 30

Werewolf Therapeutics director Luke Evnin sells USD 90,028 of common stock

Reuters
·
May 27